The preliminary agenda for our virtual MedCity INVEST Precision Medicine conference June 9-11 is now online. The conference will spotlight industry experts from providers, biopharma, diagnostic and medtech companies, and more.
The conference highlights the intersections of technology and life sciences through the prism of precision medicine. Among the panels planned for the conference are:
- A discussion on some of the projects children’s hospitals are undertaking in precision medicine
- A look at the landscape of tech companies addressing clinical trial challenges
- How companies are addressing the supply chain complexities of producing biologics and cell and gene therapies
- Non dilutive funding sources for life science startups
- Lessons learned from Covid-19 that can be applied to precision medicine from vaccine development and distribution to testing rollout.
- Our startup pitch contest, Pitch Perfect, for health tech and life science companies focused on personalized health and precision medicine.
To view the preliminary agenda, which will include on-demand content and live segments, click here.
Additionally, customized content with a precision medicine theme can be developed for sponsors. For more information, contact [email protected] or [email protected]
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
To apply to speak at INVEST Precision Medicine, please follow this link. The deadline is May 9.
Photo: SusanneB, GettyImages
